Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18820440 | Production And Delivery Tracking And Sample Verification Of Patient-Specific Therapeutics | August 2024 | November 2025 | Allow | 15 | 1 | 0 | No | No |
| 18813798 | SYSTEM AND METHOD FOR CREATION OF PERSISTENT PATIENT IDENTIFICATION | August 2024 | February 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 18805697 | SYSTEM AND METHOD FOR CREATION OF PERSISTENT PATIENT IDENTIFICATION | August 2024 | March 2025 | Allow | 7 | 1 | 0 | Yes | No |
| 18743729 | METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCE | June 2024 | November 2025 | Allow | 17 | 1 | 0 | No | No |
| 18740246 | SYNTHESIZING COMPLEX POPULATION SELECTION CRITERIA | June 2024 | July 2025 | Abandon | 13 | 1 | 0 | Yes | No |
| 18734284 | DOSING OF INCRETIN PATHWAY DRUGS | June 2024 | October 2025 | Allow | 16 | 0 | 0 | Yes | No |
| 18672436 | SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTER | May 2024 | July 2025 | Allow | 14 | 0 | 0 | Yes | No |
| 18649982 | SYSTEMS AND METHODS FOR PREDICTING PATIENT OUTCOME TO CANCER THERAPY | April 2024 | September 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18625041 | METHOD AND SYSTEM FOR AUTOMATED DIFFERENTIAL MEDICAL DIAGNOSIS ASSESMENT | April 2024 | March 2026 | Allow | 23 | 1 | 0 | Yes | No |
| 18617468 | SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTER | March 2024 | July 2025 | Allow | 15 | 1 | 0 | No | No |
| 18586281 | System and Method for Advanced Identification of a Customer | February 2024 | September 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18442432 | SYSTEMS AND METHODS FOR PRE-OPERATIVE PROCEDURE DETERMINATION AND OUTCOME PREDICTING | February 2024 | January 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18527160 | DECISION SUPPORT SYSTEMS FOR DETERMINING CONFORMITY WITH MEDICAL CARE QUALITY STANDARDS | December 2023 | July 2025 | Allow | 20 | 2 | 0 | Yes | No |
| 18523564 | Production And Delivery Tracking And Sample Verification Of Patient-Specific Therapeutics | November 2023 | June 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18501103 | METHOD AND SYSTEM TO FACILITATE PATIENT CARE | November 2023 | November 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18483142 | Order Status | October 2023 | September 2025 | Abandon | 24 | 4 | 0 | Yes | No |
| 18374767 | LABELING APPARATUS | September 2023 | July 2024 | Allow | 9 | 1 | 0 | Yes | No |
| 18468055 | METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCE | September 2023 | June 2024 | Allow | 9 | 1 | 0 | Yes | No |
| 18272692 | METHOD AND APPARATUS FOR PROCESSING SAMPLE | July 2023 | October 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18352216 | SYSTEM FOR PREDICTING END-STAGE RENAL DISEASE COMPLICATION RISK BASED ON CONTRASTIVE LEARNING | July 2023 | November 2023 | Allow | 4 | 0 | 0 | No | No |
| 18128042 | SYSTEM AND METHOD FOR ADVANCED IDENTIFICATION OF A CUSTOMER | March 2023 | November 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18190778 | DETERMINATION OF PERSONALIZED ENDOCANNABINOID GENOTYPES AND ASSOCIATED RECOMMENDATIONS | March 2023 | October 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18044722 | OPTIMIZATION SYSTEM AND METHOD FOR MEDICAL SYSTEM, AND COMPUTER-READABLE STORAGE MEDIUM | March 2023 | September 2025 | Abandon | 30 | 2 | 0 | Yes | No |
| 18181474 | HEALTH CARE DELIVERY SYSTEM AND METHOD | March 2023 | April 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18156259 | METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCE | January 2023 | August 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18096765 | AUTOMATED PHARMACY TRANSLATION ENGINE FOR PRESCRIPTION MEDICATION INSTRUCTIONS | January 2023 | June 2025 | Allow | 29 | 5 | 0 | Yes | No |
| 18094472 | AUTOMATED INTERVENTION SYSTEM BASED ON CHANNEL-AGNOSTIC INTERVENTION MODEL | January 2023 | July 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18092260 | CHANNEL-SPECIFIC ENGAGEMENT MACHINE LEARNING ARCHITECTURE | December 2022 | July 2023 | Allow | 7 | 0 | 0 | Yes | No |
| 18014141 | LEARNING DATA GENERATION DEVICE, METHOD FOR DRIVING SAME DEVICE, AND COMPUTER-READABLE RECORDING MEDIUM | December 2022 | January 2026 | Abandon | 36 | 3 | 0 | No | Yes |
| 18001036 | MEDICAL INFORMATION SYSTEM, CHARGE CALCULATING DEVICE, AND CHARGE CALCULATING METHOD | December 2022 | August 2025 | Abandon | 33 | 2 | 0 | No | No |
| 17992755 | SYSTEMS AND METHODS FOR USING MACHINE LEARNING ALGORITHMS TO IDENTIFY CARE GAPS | November 2022 | January 2026 | Allow | 38 | 1 | 0 | Yes | No |
| 18057048 | Multi-Dose Packaging Medication Administration System | November 2022 | August 2023 | Allow | 9 | 0 | 0 | Yes | No |
| 17983002 | USING NATURAL LANGUAGE PROCESSING TO FIND ADVERSE EVENTS | November 2022 | April 2024 | Allow | 17 | 2 | 0 | No | No |
| 17978677 | ENCODED GRAPHICAL MODELING SYSTEM AND METHOD FOR MATCHING PATIENTS OR MEMBERS NEEDING A PARTICULAR MEDICAL PROCEDURE OR OTHER HEALTH INTERVENTION WITH HEALTHCARE FACILITIES OR PROVIDERS | November 2022 | January 2026 | Allow | 39 | 2 | 0 | No | No |
| 17971778 | SYSTEMS AND METHODS FOR PREDICTING PATIENT OUTCOME TO CANCER THERAPY | October 2022 | December 2023 | Allow | 14 | 1 | 0 | Yes | No |
| 17955144 | Order Status | September 2022 | July 2023 | Allow | 9 | 0 | 0 | Yes | No |
| 17952307 | APPARATUS AND METHOD FOR PROVIDING PATIENT ADMINISTERED AND PHYSICIAN PRESCRIBED AND MONITORED DRUG TITRATION | September 2022 | October 2025 | Abandon | 37 | 6 | 0 | No | No |
| 17898115 | SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTER | August 2022 | January 2024 | Allow | 17 | 2 | 0 | No | No |
| 17893925 | MEDICAL INCIDENT RESPONSE AND REPORTING SYSTEM AND METHOD | August 2022 | August 2024 | Allow | 24 | 0 | 0 | Yes | No |
| 17866616 | METHOD AND SYSTEM TO FACILITATE PATIENT CARE | July 2022 | July 2023 | Allow | 12 | 0 | 0 | Yes | No |
| 17859910 | NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM, INFORMATION PROCESSING APPARATUS, AND INFORMATION PROCESSING METHOD | July 2022 | February 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17855958 | SYSTEM AND METHOD FOR ADJUSTING HOSPITAL UNIT CAPACITY BASED ON PATIENT-SPECIFIC VARIABLES | July 2022 | December 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17848993 | REMOTE MONITORING METHODS AND SYSTEMS FOR MONITORING PATIENTS SUFFERING FROM CHRONICAL INFLAMMATORY DISEASES | June 2022 | May 2025 | Abandon | 34 | 2 | 0 | Yes | No |
| 17846355 | AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND METHOD | June 2022 | January 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 17804781 | DEVICE AND METHODS FOR MACHINE LEARNING-DRIVEN DIAGNOSTIC TESTING | May 2022 | January 2025 | Allow | 32 | 1 | 0 | No | No |
| 17756177 | DELIVERY MANAGEMENT SYSTEM | May 2022 | August 2024 | Allow | 27 | 1 | 0 | Yes | No |
| 17743299 | SYSTEMS, DEVICES AND METHODS FOR DETECTING AND TRACKING DRUG EXTRACTION | May 2022 | September 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17731282 | CANCER TYPE PREDICTION SYSTEM | April 2022 | September 2025 | Abandon | 41 | 2 | 0 | No | No |
| 17729335 | SYSTEM FOR DYNAMIC LOCATION-AWARE PATIENT CARE PROCESS CONTROLS AND DYNAMIC LOCATION-AWARE TRACKING | April 2022 | September 2025 | Allow | 41 | 5 | 0 | Yes | No |
| 17658140 | REDUCING INFUSION PUMP NETWORK CONGESTION BY STAGGERING UPDATES | April 2022 | August 2023 | Allow | 17 | 1 | 0 | Yes | No |
| 17764468 | MRTHOD, DEVICE FOR DISEASE PREDICTION, ELECTRONIC DEVICE AND COMPUTER-READABLE STORAGE MEDIUM | March 2022 | September 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17700558 | AI BASED SYSTEM AND METHOD FOR PREDICITING CONTINUOUS CARDIAC OUTPUT (CCO) OF PATIENTS | March 2022 | August 2025 | Abandon | 41 | 2 | 0 | Yes | No |
| 17696059 | SYNTHESIZING COMPLEX POPULATION SELECTION CRITERIA | March 2022 | February 2024 | Allow | 23 | 3 | 0 | Yes | No |
| 17696498 | MACHINE LEARNING METHOD FOR IDENTIFYING DRUG INTERACTIONS | March 2022 | September 2025 | Abandon | 42 | 3 | 0 | No | No |
| 17629047 | AUTOMATED CLINICAL DECISION DISAMBIGUATION | January 2022 | January 2025 | Abandon | 36 | 2 | 0 | No | No |
| 17566503 | ARTIFICIAL INTELLIGENCE-BASED MEDICAL CODING AND DIAGNOSIS | December 2021 | October 2025 | Allow | 46 | 4 | 0 | Yes | No |
| 17619742 | DEVICE AT THE POINT OF IMAGING FOR INSTANT ADVICE ON CHOICES TO STREAMLINE IMAGING WORKFLOW | December 2021 | December 2024 | Abandon | 36 | 2 | 0 | No | No |
| 17644687 | METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS USING ARTIFICIAL INTELLIGENCE FOR COORDINATED IDENTIFICATION OF PATIENTS FOR A CLINICAL TRIAL BASED ON SOCIAL DETERMINANTS OF HEALTH INFORMATION | December 2021 | October 2025 | Allow | 46 | 3 | 0 | Yes | No |
| 17524352 | AI BASED CONTEXT AWARE MULTIDIRECTIONAL PATIENT MOVEMENT | November 2021 | May 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17519657 | SYSTEMS AND METHODS FOR PRE-OPERATIVE PROCEDURE DETERMINATION AND OUTCOME PREDICTING | November 2021 | November 2023 | Allow | 24 | 2 | 0 | No | No |
| 17519873 | METHOD AND APPARATUS FOR ANALYZING MEDICAL TREATMENT DATA BASED ON DEEP LEARNING | November 2021 | May 2024 | Abandon | 30 | 2 | 0 | Yes | No |
| 17514826 | DEVICES AND METHOD FOR A HEALTHCARE COLLABORATION SPACE | October 2021 | November 2024 | Allow | 37 | 1 | 0 | No | No |
| 17491661 | SYSTEM AND METHOD FOR INITIATING TELEMEDICINE CONFERENCE USING SELF-DIAGNOSTIC TEST | October 2021 | February 2024 | Abandon | 29 | 2 | 0 | No | No |
| 17491829 | System and Methods for Providing Inductive Sensing of Sharps and Other Medical Instruments | October 2021 | March 2025 | Allow | 41 | 3 | 0 | No | No |
| 17437964 | METHOD AND SYSTEM FOR PROVIDER NETWORK OPTIMIZATION BASED ON IDENTIFICATION OF HIGH-PRIORITY AREAS WITH TARGETED POPULATIONS BY A HEALTH ECONOMICS APPROACH | September 2021 | January 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17462931 | NETWORK USER DATA DELIVERY | August 2021 | August 2025 | Allow | 48 | 3 | 0 | Yes | No |
| 17461190 | System and Method for Creation of Persistent Patient Identification | August 2021 | September 2024 | Allow | 37 | 2 | 0 | Yes | No |
| 17384879 | UNIVERSAL PHYSICIAN RANKING SYSTEM BASED ON AN INTEGRATIVE MODEL OF PHYSICIAN EXPERTISE | July 2021 | August 2023 | Abandon | 25 | 4 | 0 | No | No |
| 17381956 | GEOLOCATION PATHOGEN-RISK ASSESSMENT WITH PANDEMIC-BIO-SURVEILLANCE MULTI PATHOGEN SYSTEMS | July 2021 | July 2022 | Allow | 11 | 2 | 0 | No | No |
| 17381932 | NATURAL-LANGUAGE TEXT GENERATION WITH PANDEMIC-BIO-SURVEILLANCE MULTI PATHOGEN SYSTEMS | July 2021 | May 2025 | Abandon | 46 | 3 | 0 | Yes | No |
| 17378245 | PREDICTING ADDICTION RELAPSE AND DECISION SUPPORT TOOL | July 2021 | November 2023 | Allow | 28 | 2 | 0 | Yes | No |
| 17419283 | PREDICTION OF USAGE OR COMPLIANCE | June 2021 | June 2025 | Allow | 48 | 3 | 0 | Yes | No |
| 17323138 | SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTER | May 2021 | December 2023 | Allow | 31 | 2 | 0 | No | No |
| 17294514 | EMERGENCY DEMAND PREDICTION DEVICE, EMERGENCY DEMAND PREDICTION METHOD, AND PROGRAM | May 2021 | February 2024 | Allow | 33 | 1 | 0 | Yes | No |
| 17221384 | SYSTEM AND METHOD FOR GENERATING A PROCREANT FUNCTIONAL PROGRAM | April 2021 | June 2024 | Allow | 38 | 1 | 0 | Yes | No |
| 17218487 | METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS USING ARTIFICIAL INTELLIGENCE FOR COORDINATED IDENTIFICATION OF PATIENTS FOR A CLINICAL TRIAL THAT ARE SERVED BY MULTIPLE PROVIDERS | March 2021 | October 2025 | Allow | 55 | 5 | 0 | Yes | No |
| 17206707 | LABELING APPARATUS | March 2021 | May 2023 | Allow | 26 | 1 | 0 | No | No |
| 17271144 | APHERESIS DEVICES FLEET MANAGEMENT SYSTEM AND METHOD | February 2021 | December 2025 | Allow | 58 | 5 | 0 | Yes | No |
| 17169640 | AUTOMATED PHARMACY TRANSLATION ENGINE FOR PRESCRIPTION MEDICATION INSTRUCTIONS | February 2021 | September 2022 | Allow | 20 | 0 | 0 | Yes | No |
| 17248299 | Patient-Facing App for Health Literacy and Numeracy | February 2021 | July 2023 | Abandon | 30 | 1 | 0 | No | No |
| 17161092 | METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCE | January 2021 | October 2022 | Allow | 20 | 0 | 0 | Yes | No |
| 17154981 | SYSTEM AND METHOD FOR ON-DEMAND ONLINE CONSULTATION | January 2021 | April 2023 | Abandon | 27 | 1 | 0 | No | No |
| 17248295 | System For Interpreting And Managing Diet And Medication Interactions | January 2021 | May 2023 | Abandon | 27 | 1 | 0 | Yes | No |
| 17248300 | Patient-Facing App for Health Literacy and Numeracy | January 2021 | April 2023 | Abandon | 27 | 1 | 0 | Yes | No |
| 17248297 | System For Interpreting And Managing Health Information | January 2021 | June 2023 | Abandon | 29 | 1 | 0 | No | No |
| 17137721 | EMR INTEGRATED ELECTRONIC CASE REPORTING | December 2020 | October 2024 | Abandon | 46 | 1 | 0 | Yes | No |
| 17136199 | SYSTEM AND METHOD FOR GENERATING A PROCREANT NOURISHMENT PROGRAM | December 2020 | February 2021 | Allow | 2 | 0 | 0 | No | No |
| 17132731 | SYSTEMS AND METHODS FOR DISPENSING A STATIN MEDICATION OVER THE COUNTER | December 2020 | April 2022 | Allow | 16 | 0 | 0 | No | No |
| 17118872 | SYSTEMS AND METHODS FOR PREDICTIVE ANOMALY DETECTION IN PHARMACEUTICAL PROCESSING DATA | December 2020 | February 2025 | Allow | 50 | 2 | 0 | Yes | No |
| 17095504 | CHANNEL-SPECIFIC ENGAGEMENT MACHINE LEARNING ARCHITECTURE | November 2020 | November 2022 | Allow | 25 | 1 | 0 | Yes | No |
| 17052464 | DISEASE NETWORK CONSTRUCTION METHOD CONSIDERING STRATIFICATION ACCORDING TO CONFOUNDING VARIABLE OF COHORT DATA AND OCCURRENCE TIME BETWEEN DISEASES, METHOD FOR VISUALIZING SAME, AND COMPUTER READABLE RECORDING MEDIUM RECORDING SAME | November 2020 | July 2022 | Abandon | 20 | 1 | 0 | No | No |
| 17074442 | METHODS AND SYSTEMS FOR MANAGING PATIENT TREATMENT COMPLIANCE | October 2020 | January 2021 | Allow | 3 | 0 | 0 | No | No |
| 17068043 | REDUCING INFUSION PUMP NETWORK CONGESTION BY STAGGERING UPDATES | October 2020 | January 2022 | Allow | 15 | 0 | 0 | Yes | No |
| 17065447 | APPARATUS AND METHOD FOR PROVIDING PATIENT ADMINISTERED AND PHYSICIAN PRESCRIBED AND MONITORED DRUG TITRATION | October 2020 | September 2022 | Abandon | 24 | 1 | 0 | No | No |
| 17061175 | Order Status | October 2020 | June 2022 | Allow | 21 | 1 | 0 | Yes | No |
| 17035676 | HEALTH CARE DELIVERY SYSTEM AND METHOD | September 2020 | June 2022 | Abandon | 21 | 1 | 0 | No | No |
| 17005935 | PATIENT MANAGEMENT BASED ON SENSED INPUTS | August 2020 | April 2025 | Allow | 55 | 4 | 0 | Yes | No |
| 16939324 | Automated Healthcare Provider Quality Reporting System (PQRS) | July 2020 | May 2022 | Abandon | 21 | 1 | 0 | No | No |
| 16939244 | METHOD OF AND SYSTEM FOR GENERATING A STRESS BALANCE INSTRUCTION SET FOR A USER | July 2020 | April 2024 | Allow | 45 | 2 | 0 | Yes | No |
| 16940337 | FINGERPRINT ENHANCED AUTHENTICATION FOR MEDICAL DEVICES IN WIRELESS NETWORKS | July 2020 | February 2022 | Allow | 19 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HEIN, DEVIN C.
With a 5.6% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HEIN, DEVIN C works in Art Unit 3686 and has examined 276 patent applications in our dataset. With an allowance rate of 46.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.
Examiner HEIN, DEVIN C's allowance rate of 46.0% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HEIN, DEVIN C receive 2.67 office actions before reaching final disposition. This places the examiner in the 78% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by HEIN, DEVIN C is 40 months. This places the examiner in the 25% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +28.0% benefit to allowance rate for applications examined by HEIN, DEVIN C. This interview benefit is in the 75% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 14.2% of applications are subsequently allowed. This success rate is in the 10% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 11.6% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 25.0% of appeals filed. This is in the 3% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 10.8% are granted (fully or in part). This grant rate is in the 8% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.